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Abstract 
Introduction: Since the outbreak of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) began, nec-
essary measures to prevent virus transmission and reduce mortality have been implemented, including mandatory 
public use of masks, regular hand-sanitizing and hand-washing, social distancing, avoidance of crowds, remote work, 
and cancellation of public events. During and after the introduction of COVID-19 lockout, we performed a systematic 
review of available published literature to investigate the incidence of seasonal influenza and other respiratory viral 
infections.
Methods: PubMed, Embase, Web of Science, Scopus, Science Direct, Google Scholar, Research Gate, and the World 
Health Organization databases and websites were systematically searched for original studies concerning the impact 
of COVID-19 prevention means and measures on other common respiratory infectious diseases during the pandemic 
published by March 2021.
Results: The findings showed that the adherence to health protocols to prevent COVID-19 could help to reduce the 
incidence of other infectious diseases such as influenza, pneumonia, and Mycobacterium tuberculosis.
Conclusion: The implemented prevention measures and protocols might have reduced the incidence of influenza 
and some other common respiratory infections. However, controversies exist on this matter and future large popula-
tion-based studies might provide further information to address these controversies.
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Introduction
Since the beginning of the severe acute respiratory syn-
drome coronavirus-2 (SARS-CoV-2) outbreak, necessary 
measures have been taken to prevent the virus trans-
mission and reduce mortality, such as mandatory public 
use of mask, regular hand-sanitizing and hand-washing, 
remote work, social distancing, avoid gatherings, and 
cancellation of public events [1]. Limiting contact is a 
strategy that aims to reduce both the frequency and dura-
tion of contacts, lowering the basic reproduction num-
ber, R0, or the average number of people to whom one 
case transmits the disease during his or her incubation 
period [2].
As a control measure, China was the first country to 
implement a regional lockdown of cities in Hubei prov-
ince. Wuhan, the largest city in Hubei province, with a 
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76-day lockdown. Other countries, including Italy (prov-
inces of Lombardy and Veneto), Spain, Russia, India, 
and the Philippines, later used similar lockdowns, with 
durations ranging from as little as 4 days in Turkey to 
as long as nearly a year in Qatar (3Oraby). Studies have 
shown that strategies have been effective in preventing 
the spread of the disease and reducing the incidence and 
mortality rates [2–4].
It is hypothesized that SARS-CoV-2 measures may also 
be effective in reducing other respiratory infectious dis-
eases, such as seasonal influenza, outpatient pneumonia, 
scarlet fever, and severe acute respiratory illness (SARI) 
[5, 6]. Findings of recent study conducted in New Zea-
land showed that after 9 months of lockdown, the inci-
dence of influenza decreased 79-fold. They have also 
reported a significant reduction in the incidence of other 
respiratory viruses during post-lockdown in comparison 
with the same time in the past year [7]. A reduction in 
the number of people infected with the influenza virus in 
2020 compared to the previous year was also observed in 
a study from Japan [8]. Here, we assessed the reduction 
of the seasonal influenza virus incidence and respiratory 




We systematically searched PubMed, Embase, Web 
of Science, Scopus, Science Direct, Google Scholar, 
Research Gate, and the World Health Organization data-
bases and websites. After conducting the search protocol, 
two researchers performed a two-step screening process. 
First, they screened the title/abstract of the retrieved 
records. Then, the selected articles in the first step under-
went a full-text screening and the eligible studies were 
identified.
Research question
We aimed to answer the following main question:
• What was the impact of COVID-19 prevention 
means and measures on other common respiratory 
infectious diseases during the pandemic?
Search strategy
We included the final search entry [C] for this systematic 
review:
A. [Viral infection] (Title/Abstract) OR [SARS] (Title/
Abstract) OR [Respiratory tract infection] (Title/
Abstract) OR [Interstitial lung diseases] (Title/
Abstract) OR [Influenza] (Title/Abstract) OR 
[Inflammation] (Title/Abstract)
B. [Coronavirus] (Title/Abstract) OR [COVID-19] 
(Title/Abstract) OR [SARS-CoV-2] (Title/Abstract) 
OR [Corona] (Title/Abstract) OR [COVID] (Title/
Abstract)OR [Coronavirus infection] (Title/Abstract)
OR [Pandemic] (Title/Abstract)
C. [A] AND [B]
Eligibility criteria
English articles relevant to our research question from 
the start of the pandemic (December 2019) until March 
2021 were included.
The exclusion criteria were as follows:
• Review articles, editorial, commentaries, opinions, or 
any studies with no original data
• Ongoing projects (e.g., articles discussing the proto-
col of a future study)
• Non-human (e.g., animal and laboratory) studies
• Duplicated results in databases.
Data collection
Two researchers read the full texts of the eligible articles 
and extracted the relevant findings. The collected data 
were utilized to construct the results section.
Results
In this study, 147 documents were identified using a 
systematic search strategy. After a primary review of 
retrieved articles, 16 duplicates were removed, and 
the title and abstract of the remaining were reviewed. 
After applying the selection criteria, 102 articles were 
excluded, and only 29 articles met the inclusion criteria 
and were included in the final review (Fig. 1). These stud-
ies were conducted in Taiwan (n = 9), between countries 
(n = 4), Singapore (n = 3), Japan (n = 2), South Korea 
(n = 2), China (n = 2), Hong Kong (n = 1), Mexico (n = 1), 
the Netherlands (n = 1), the European region (n = 1), 
Israel (n = 1), Pakistan (n = 1), and the USA (n = 1) and 
explored the effect of COVID-19 prevention measures on 
other respiratory infectious diseases. From 29 included 
studies, 25 were related to influenza, four related to 
Mycobacterium tuberculosis, four related to pneumo-
nia, three related to rhinovirus, three related to other 
coronaviruses, three related to enterovirus, two related 
to adenovirus, and only one study was related to several 
respiratory infections.
The present study results showed that adherence to 
the COVID-19 preventive measures and protocols could 
be protective and reduce the incidence of some other 
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respiratory infectious diseases such as influenza, pneu-
monia, and Mycobacterium tuberculosis.
Discussion
SARS-CoV-2, a novel coronavirus responsible for 
COVID-19, was first reported in China in late 2019 
and then spread out rapidly worldwide [35]. COVID-19 
attracted worldwide attention as an international pub-
lic health emergency and the first pandemic caused by a 
coronavirus [36]. Many attempts were made to control 
the situation, such as border controls, social distancing, 
community education, lockdown, compulsory wearing 
of masks in public, and school closures [37–40]. These 
public health measures not only reduced SARS-CoV-2 
transmission, but might also reduce transmission of other 
endemic viral respiratory infections [10]. In this study, we 
gathered and reported the findings that support or reject 
this hypothesis.
One of the respiratory viruses is influenza. Influenza is 
one of the most common respiratory infectious diseases 
and a highly contagious airborne disease that occurs as 
seasonal epidemics and manifests as an acute febrile ill-
ness with variable degrees of systemic symptoms [41]. 
Public health interventions and changes (such as stay-
at-home orders, movement restrictions, face mask use, 
and school closures) in response to the SARS-CoV-2 out-
break unintentionally led to the reduction of influenzas 
spread in 2020 [10, 11]. Singh S et al. have noted an initial 
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increase in influenza testing in southeastern Wisconsin 
followed by a dramatic decline in detection of seasonal 
influenza coinciding with the outbreak of SARS-CoV-2 
[27]. They found that the decline in influenza detection 
during the 2019–2020 seasons could have been due to 
less testing for influenza, which may have happened if 
clinicians had started testing preferentially for SARS-
CoV-2 during this period. However, they also responded 
to this by stating that influenza testing was probably 
much higher or the same during this period compared to 
previous years. As influenza and SARS-CoV-2 are symp-
tomatically indistinguishable, they concluded that it is 
highly unlikely that patients with influenza decided to 
avoid seeking medical care [27]. Young G et al. have also 
found that implementing public health measures in the 
early fall, warranted by the first signs of either influenza 
or COVID-19 outbreaks, may help to reduce the trans-
mission of both respiratory illnesses. However, they were 
concerned about the potential impact of a second wave of 
COVID-19 during the upcoming influenza season in the 
upcoming autumn [34].
Following a period of reduction in COVID-19 trans-
mission over the summer, most countries observed a rise 
in COVID-19 cases and initiated using various preven-
tive public health and social measures [32]. The continu-
ation or re-implementation of several public health and 
social measures led to an overall reduction in circulating 
influenza viruses again during the winter months com-
pared with previous seasons, particularly considering the 
lower basic reproduction number (R0) of influenza com-
pared with SARS-CoV-2 [32]. Singh S et al. showed that 
convincing the public to change its lifestyle through pol-
icy and information—as was gained at the outset of the 
SARS-CoV-2 outbreak—could again reduce the impact of 
a “double hit” at fall and winter. These efforts saved lives 
directly by reducing the incidence of seasonal influenza 
and SARS-CoV-2, and indirectly by reducing the burden 
on the health system [27].
Nevertheless, this theory might not be entirely correct, 
and some findings are controversial. For instance, the 
number of documented Influenza and pneumonia deaths 
in the US was higher in 2020 than in 2019. Documented 
influenza and pneumonia deaths increased by 7.5% in 
2020, although the number of influenza and pneumonia 
deaths was lower in 2020 than in 2017 and 2018 [42]. 
However, there is a concern that wrong death certificates 
might alter the reality of the situation, especially in the 
pandemic where the high burden might have resulted in 
wrong findings and documentation, especially for dis-
eases with similar manifestations such as influenza and 
COVID-19 [43, 44].
Besides influenza, studies show a meaningful reduction 
in the activity and reported cases of other respiratory 
germs such as Mycobacterium tuberculosis, pneumonia, 
rhinovirus, enterovirus, adenovirus, and several other 
respiratory infectious diseases mentioned in Table  1 [5, 
19, 20, 22, 25, 26, 29]; however, many of them are scarcely 
investigated. For example, measles cases in Taiwan were 
reported to be zero after the pandemic, possibly owing to 
the implemented precautions during the pandemic [12]. 
In supporting the above-mentioned conclusion, Lai CC 
et al. have noticed the significant decline of tuberculosis 
activity during the COVID-19 outbreak in Taiwan. Drop-
let aerosol precaution and prevention measures may offer 
success in containing SARS-CoV-2 transmission and 
collateral benefits in controlling tuberculosis [20]. How-
ever, Komiya K et al. have another idea about these sta-
tistics and explain them in another way. They think that 
the statistical decline in tuberculosis incidence following 
the COVID-19 outbreak is likely to have been influenced 
by the decreased number of tests for  M. tuberculosis 
and may not reflect the true incidence of tuberculosis in 
Japan. They justified this by stating that the reactivation 
of tuberculosis among the elderly cannot be controlled by 
short-term measures for preventing SARS-CoV-2 trans-
mission [18].
This study has several limitations. First, it has been 
more than a year since the beginning of the COVID-19 
pandemic; however, many aspects are still unknown and 
limited studies are available regarding the effect of the 
COVID-19 prevention measures on the spread of other 
respiratory infections. Second, many studies came from 
specific parts of the world; for example, Southeast Asia is 
responsible for a significant part of the studies discussed 
in our review. Therefore, the knowledge of the various 
endemic patterns related to other regions in the world 
is limited and we were not able to discuss it in detail. At 
last, novel studies might contradict the findings of our 
study as the knowledge on the current pandemic and its 
effects are rapidly evolving worldwide. Overall, this study 
presented novel findings on the effect of the COVID-19 
prevention measures on several infections and provided 
valuable information to conduct future studies.
Conclusion
In conclusion, most of the studies suggested that the 
implemented preventive COVID-19 protocols have con-
trolled and reduced the outbreaks of influenza and sev-
eral other respiratory infectious diseases. The impact 
of the COVID-19 pandemic and the prevention meas-
ures on other respiratory infections could be attrib-
uted to an increase in positive testing, reduction in the 
patients with these infectious diseases, or in some cases, 
it might be due to the increased mortality of these dis-
eases. However, the overall findings indicate the positive 
effect of COVID-19 preventive measures on controlling 
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the seasonal endemics of other respiratory diseases; even 
though controversies still exist, and further studies are 
needed to clarify the exact impact of the COVID-19 on 
other respiratory infections.
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